相似文献
1
Urine bactericidal activity after administration of gemifloxacin and trovafloxacin single doses in a phase I study.
Int J Antimicrob Agents. 2002 Dec;20(6):477-80. doi: 10.1016/s0924-8579(02)00242-x.
2
Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.
Antimicrob Agents Chemother. 2001 Jun;45(6):1876-8. doi: 10.1128/AAC.45.6.1876-1878.2001.
3
Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers.
Antimicrob Agents Chemother. 2001 Dec;45(12):3524-30. doi: 10.1128/AAC.45.12.3524-3530.2001.
4
Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships.
Diagn Microbiol Infect Dis. 2001 Aug;40(4):167-71. doi: 10.1016/s0732-8893(01)00264-4.
5
The bactericidal activity of gemifloxacin (SB-265805).
J Med Microbiol. 2000 Sep;49(9):841-844. doi: 10.1099/0022-1317-49-9-841.
6
Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers.
Antimicrob Agents Chemother. 2001 Feb;45(2):608-11. doi: 10.1128/AAC.45.2.608-611.2001.
7
Influence of diminished susceptibility of Streptococcus pneumoniae to ciprofloxacin on the serum bactericidal activity of gemifloxacin and trovafloxacin after a single dose in healthy volunteers.
Int J Antimicrob Agents. 2001 Sep;18(3):231-8. doi: 10.1016/s0924-8579(01)00392-2.
8
Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae.
Int J Antimicrob Agents. 2002 Aug;20(2):144-6. doi: 10.1016/s0924-8579(02)00119-x.
9
In vitro activity of gemifloxacin and five other fluoroquinolones against defined isogenic mutants of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.
J Antimicrob Chemother. 2000 Dec;46(6):1037-8. doi: 10.1093/jac/46.6.1037.
10
Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2003 Jan;47(1):440-1. doi: 10.1128/AAC.47.1.440-441.2003.
Zotero 插件